Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors

Life Sciences

Volumn 65, Issue 6-7, 1999, Pages 597-605

  Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

AM630; CB2 like receptors; Guinea pig small intestine; Mouse vas deferens; Palmitoylethanolamide; Peripheral cannabinoid CB1 receptors

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; RIMONABANT; DRUG RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; DRUG RECEPTOR BINDING; INTESTINE MOTILITY; MOUSE; MYENTERIC PLEXUS; NERVE CELL; NONHUMAN; RECEPTOR AFFINITY; SWINE; ANIMAL; CHEMISTRY; GENETICS; HUMAN; PERIPHERAL NERVE; REVIEW;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

ANIMALS; HUMANS; NEURONS; PERIPHERAL NERVES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER;

EID: 0033538346     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00282-9     Document Type: Article

References (54)

1. R.G. Pertwee, Pharmacol. Ther. 74 129-180 (1997).
2. M. Glass and C.C. Felder, J. Neurosci. 17 5327-5333 (1997).
3. G.B. Stefano, Y. Liu and M.S. Goligorsky, J. Biol. Chem. 271 19238-19242 (1996).
4. F. Barth, Exp. Opin. Ther. Patents 8 301-313 (1998).
5. R.G. Pertwee, Biochem. Soc. Transact. 26 267-272 (1998).
6. R.G. Pertwee, Exp. Opin. Invest. Drugs 5 1245-1253 (1996).
7. R.G. Pertwee, Pharmaceut. Sci. 3 539-545 (1997).
8. A. Pério, M. Rinaldi-Carmona, J. Maruani, F. Barth, G. Le Fur and P. Soubrié, Behav. Pharmacol. 7 65-71 (1996).
9. J.D. Richardson, L. Aanonsen and K.M. Hargreaves, Eur J Pharmacol 345 145-153 (1998).
10. E.J.N. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Abood and G. Kunos, Br. J. Pharmacol. 118 2023-2028 (1996).
11. N.E. Buckley, S. Hansson, G. Harta and É. Mezey, Neuroscience 82 1131-1149 (1998).
12. A.A. Coutts and R.G. Pertwee, Br. J. Pharmacol. 121 1557-1566 (1997).
13. G. Griffin, S.R. Fernando, R.A. Ross, N.G. McKay, M.L.J. Ashford, D. Shire, J.W. Huffman, S. Yu, J.A.H. Lainton and R.G. Pertwee, Eur. J. Pharmacol. 339 53-61. (1997).
14. F. López-Redondo, G.M. Lees and R.G. Pertwee, Br. J. Pharmacol. 122 330-334 (1997).
15. A.A. Coutts and R.G. Pertwee, Can. J. Physiol. Pharmacol. 76 340-346 (1998).
16. A.A. Izzo, N. Mascolo, F. Borrelli and F. Capasso, Br. J. Pharmacol. 124 1363-1368 (1998).
17. R. Pertwee, S. Fernando, J. Ritchie and R. Ross, Symposium on the Cannabinoids, p. 127, Burlington, Vermont, International Cannabinoid Research Society (1998).
18. R.A. Ross, H.C. Brockie, S.R. Fernando, B. Saha, R.K. Razdan and R.G. Pertwee, Br. J. Pharmacol. 125 1345-1351 (1998).
19. R.G. Pertwee and S.R. Fernando, Br. J. Pharmacol. 118 2053-2058 (1996).
20. T. Croci, L. Manara, G. Aureggi, F. Guagnini, M. Rinaldi-Carmona, J.-P. Maffrand, G. Le Fur, S. Mukenge and G. Ferla, Br. J. Pharmacol. 125 1393-1395 (1998).
21. R.G. Pertwee, L.A. Stevenson, D.B. Elrick, R. Mechoulam and A.D. Corbett, Br. J. Pharmacol. 105 980-984 (1992).
22. R.G. Pertwee, S.R. Fernando, J.E. Nash and A.A. Coutts, Br. J. Pharmacol. 118 2199-2205 (1996).
23. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.-C. Brelière and G. Le Fur, FEBS Lett. 350 240-244 (1994).
24. V.M. Showalter, D.R. Compton, B.R. Martin and M.E. Abood, J. Pharmacol. Exp. Ther. 278 989-999 (1996).
25. M. Rinaldi-Carmona, F. Barth, J. Millan, J.-M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.-C. Brelière and G. Le Fur, J. Pharmacol. Exp. Ther. 284 644-650 (1998).
26. A. Calignano, G. La Rana, A. Makriyannis, S.Y. Lin, M. Beltramo and D. Piomelli, Eur. J. Pharmacol. 340 R7-R8 (1997).
27. G. Colombo, R. Agabio, C. Lobina, R. Reali and G.L. Gessa, Eur. J. Pharmacol. 344 67-69 (1998).
28. M. Bouaboula, S. Perrachon, L. Milligan, X. Canat, M. Rinaldi-Carmona, M. Portier, F. Barth, B. Calandra, F. Pecceu, J. Lupker, J.-P. Maffrand, G. Le Fur and P. Casellas, J. Biol. Chem. 272 22330-22339 (1997).
29. S.J. Maclennan, P.H. Reynen, J. Kwan and D.W. Bonhaus, Br. J. Pharmacol. 124 619-622 (1998).
30. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton, R.G. Pertwee, G. Griffin, M. Bayewitch, J. Barg and Z. Vogel, Biochem. Pharmacol. 50 83-90 (1995).
31. R.G. Pertwee, S.R. Fernando, G. Griffin, V. Abadji and A. Makriyannis, Eur. J. Pharmacol. 272 73-78 (1995).
32. S.K. Goparaju, N. Ueda, H. Yamaguchi and S. Yamamoto, FEBS Lett. 422 69-73 (1998).
33. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.-C. Schwartz and D. Piomelli, Nature 372 686-691 (1994).
34. D. Shire, C. Carillon, M. Kaghad, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, D. Caput and P. Ferrara, J. Biol. Chem. 270 3726-3731 (1995).
35. M. Rinaldi-Carmona, B. Calandra, D. Shire, M. Bouaboula, D. Oustric, F. Barth, P. Casellas, P. Ferrara and G. Le Fur, J. Pharmacol. Exp. Ther. 278 871-878 (1996).
36. E.S. Onaivi, A. Chakrabarti, E.T. Gwebu and G. Chaudhuri, Behav. Brain Res. 72 115-125 (1996).
37. S.D. Skaper, A. Buriani, R. Dal Toso, L. Petrelli, S. Romanello, L. Facci and A. Leon, Proc. Nat. Acad. Sci. USA 93 3984-3989 (1996).
38. J. Qureshi, M. Saady, A. Cardounel and M. Kalimi, Mol. Cell. Biochem. 181 21-27 (1998).
39. F. Petitet, B. Jeantaud, M. Capet and A. Doble, Biochem. Pharmacol. 54 1267-1270 (1997).
40. B.F. Thomas, A.F. Gilliam, D.F. Burch, M.J. Roche and H.H. Seltzman, J. Pharmacol. Exp. Ther. 285 285-292 (1998).
41. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin and A.C. Howlett, Mol. Pharmacol. 34 605-613 (1988).
42. D.B. Houston and A.C. Howlett, Cell. Signalling. 10 667-674 (1998).
43. D.E. Selley, S. Stark, L.J. Sim and S.R. Childers, Life Sci. 59 659-668 (1996).
44. C.S. Breivogel, L.J. Sim and S.R. Childers, J. Pharmacol. Exp. Ther. 282 1632-1642 (1997).
45. S.P. Welch, J.W. Huffman and J. Lowe, J. Pharmacol. Exp. Ther. 286 1301-1308 (1998).
46. A. Calignano, G. La Rana, A. Giuffrida and D. Piomelli, Nature 394 277-281 (1998).
47. T. Sheskin, L. Hanus, J. Slager, Z. Vogel and R. Mechoulam, J. Med. Chem. 40 659-667 (1997).
48. R.G. Pertwee, G. Griffin, J.A.H. Lainton and J.W. Huffman, Eur. J. Pharmacol. 284 241-247 (1995).
49. R.G. Pertwee and G. Griffin, Eur. J. Pharmacol. 272 67-72 (1995).
50. R. Pertwee, G. Griffin, S. Fernando, X. Li, A. Hill and A. Makriyannis, Life Sci. 56 1949-1955 (1995).
51. A.D. Khanolkar, V. Abadji, S. Lin, W.A.G. Hill, G. Taha, K. Abouzid, Z. Meng, P. Fan and A. Makriyannis, J. Med. Chem. 39 4515-4519 (1996).
52. Y. Hosohata, R.M. Quock, K. Hosohata, A. Makriyannis, P. Consroe, W.R. Roeske and H.I. Yamamura, Eur. J. Pharmacol. 321 R1-R3 (1997).
53. K. Hosohata, R.M. Quock, Y. Hosohata, T.H. Burkey, A. Makriyannis, P. Consroe, W.R. Roeske and H.I. Yamamura, Life Sci. 61 PL115-118 (1997).
54. R.A. Ross, H.C. Brockie, L.A. Stevenson, V.L. Murphy, F. Templeton, A. Makriyannis and R.G. Pertwee, Br. J. Pharmacol. 126 665-672 (1999).